Weisi Medical (688580.SH) Controlling Shareholder Proposes Share Repurchase Plan Worth RMB 20–40 Million

Wisdom Finance APP reported that VISHEE (688580.SH) announced that on November 6, 2023, the company's board of directors received a letter from Mr. Wang Zhiyu, the chairman of the board and general manager, controlling shareholder, and actual controller of the company, titled "Proposal for Nanjing Vishee Medical Technology Co., Ltd. to Repurchase Company Shares." Mr. Wang Zhiyu proposed to the company’s board of directors to repurchase part of the company's shares through the Shanghai Stock Exchange trading system via centralized bidding. The repurchased shares will be used for equity incentives or for converting convertible corporate bonds issued by the listed company into stocks at a suitable time in the future. The source of funds for the share repurchase will come from the company's own funds. The total amount of funds for the share repurchase will be no less than 20 million yuan and no more than 40 million yuan. The upper limit of the repurchase price per share will not exceed 150% of the average trading price of the company's stock over the 30 trading days prior to the resolution passed by the company’s board of directors approving the repurchase plan.